Literature DB >> 3020074

Ectopic adrenocorticotropin syndrome caused by lung cancer that responded to corticotropin-releasing hormone.

T Suda, M Kondo, R Totani, N Hashimoto, M Suzuki, T Imaki, Y Oba, N Tomori, F Yajima, T Sumitomo.   

Abstract

ACTH responses to corticotropin-releasing hormone (CRH) were studied in three patients with the ectopic ACTH syndrome caused by lung cancer. Plasma ACTH responded to synthetic CRH in two of three patients. Tumor tissues obtained from these two patients contained CRH and ACTH. In one patient, tumor ACTH secretion was stimulated by CRH in vitro. Tumor CRH was immunologically, chromatographically, and biologically similar to hypothalamic CRH. In addition, multiple forms of immunoreactive beta-endorphin were present in plasma and the tumor extracts. From these results, we conclude that some patients with the ectopic ACTH syndrome have tumors that produce both ACTH and CRH and that CRH can stimulate ACTH secretion by such tumors. Other patients with the ectopic ACTH syndrome do not have ACTH responses to CRH. Therefore, procedures other than CRH testing are needed to differentiate patients with Cushing's syndrome due to ectopic ACTH/CRH production from those with Cushing's disease, since the latter also usually have ACTH responses to CRH.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020074     DOI: 10.1210/jcem-63-5-1047

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.

Authors:  T Suda; F Tozawa; I Dobashi; N Horiba; N Ohmori; M Yamakado; M Yamada; H Demura
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Cushing's syndrome in medullary thyroid carcinoma.

Authors:  A Mure; C Gicquel; N Abdelmoumene; F Tenenbaum; C Francese; J P Travagli; P Gardet; M Schlumberger
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

3.  Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and beta-endorphin measurements as markers of lung cancer.

Authors:  A E Calogero; G Minacapilli; A M Nicolosi; M L Moncada; A Mistretta; S F Latteri; P Polosa; R D'Agata
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

4.  Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome.

Authors:  R J Auchus; G Mastorakos; T C Friedman; G P Chrousos
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.